Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep 18;398(10305):1038-1041.
doi: 10.1016/S0140-6736(21)01854-7. Epub 2021 Aug 13.

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Collaborators, Affiliations
Comment

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Edward J Carr et al. Lancet. .

Erratum in

  • Department of Error.
    [No authors listed] [No authors listed] Lancet. 2021 Sep 18;398(10305):1042. doi: 10.1016/S0140-6736(21)01890-0. Epub 2021 Aug 17. Lancet. 2021. PMID: 34416197 Free PMC article. No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CS reports grants from BMS, Ono-Pharmaceuticals, BoehringerIngelheim, Roche-Ventana, Pfizer, and Archer Dx, unrelated to this Correspondence; personal fees from Genentech, Sarah Canon Research Institute, Medicxi, Bicycle Therapeutics, GRAIL, Amgen, AstraZeneca, BMS, Illumina, GlaxoSmithKline, MSD, and Roche-Ventana, unrelated to this Correspondence; and stock options from Apogen Biotech, Epic Biosciences, GRAIL, and Achilles Therapeutics, unrelated to this Correspondence. PBM reports personal fees and non-financial support from Vifor, Napp, Pharmacosmos, Astra Zeneca, Astellas, and Novartis; and grants from Boehringer Ingelheim. RB and DLVB are members of the Genotype-to-Phenotype UK National Virology Consortium. All other authors declare no competing interests. Funding details and acknowledgments can be found in the appendix. All data (anonymised) and full R code to produce figures and statistical analysis presented in this Correspondence are available online. Members of the Haemodialysis COVID-19 consortium and the Crick COVID Immunity Pipeline are listed in the appendix.

Comment in

  • Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
    Carr EJ, Wu M, Harvey R, Billany RE, Wall EC, Kelly G; Haemodialysis COVID-19 Consortium, Crick COVID Immunity Pipeline; Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL, Graham-Brown MP, Jones RB, Smith RM, McAdoo S, Willicombe M, Beale R. Carr EJ, et al. Lancet. 2022 Feb 26;399(10327):800-802. doi: 10.1016/S0140-6736(22)00104-0. Epub 2022 Jan 20. Lancet. 2022. PMID: 35065703 Free PMC article. No abstract available.

Comment on

Similar articles

Cited by

References

    1. UK Renal Registry . The Renal Association; Bristol: 2020. UK Renal Registry (2020) COVID-19 surveillance report for renal centres in the UK: a summary of the first wave of the pandemic – March to August 2020.
    1. Li KK, Woo YM, Stirrup O, et al. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. J Infect. 2021;83:96–103. - PMC - PubMed
    1. Public Health England . Public Health England; London: 2021. Immunisation against infectious disease: the Green Book.
    1. Alcázar-Arroyo R, Portolés J, López-Sánchez P, et al. Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study. Clin Kidney J. 2021;14:1835–1844. - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed